We identified that mice therapy responders displayed significantly increased frequency of anti-tumor immune cells, such as CD4+ and CD8+ T cells, antigen-presenting dendritic cells, myeloid cells, and a trend for increased frequency for NK cells (Figure 2B). This evidence concerns the gene CD8A and neoplasm.